Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Vopr Virusol ; 39(3): 125-8, 1994.
Article in Russian | MEDLINE | ID: mdl-8091753

ABSTRACT

Natural killer cell activity (NK) in parallel with the interferon (IFN)-alpha and IFN-gamma production as well as with a level of IFN in the blood serum were studied in 15 patients with relapsing herpes genitalis (RHG). Rhidostin, well known as an IFN-alpha inducer, was used in a dose of 2 mg once daily for 3 days subcutaneously up to a total dose of 8 mg of the preparation. The NK cell activity and IFN-alpha production were shown to decrease in RHG more significantly in the stage of remission than during the relapse of the process. As a result of rhidostin therapy the NK cell activity was restored simultaneously with the positive clinical effect of the drug. Rhidostin was found to be an efficient modifier of the IFN system functioning in patients with RHG. The above data allow a conclusion that rhidostin exhibiting an independent antiviral and immunostimulating action might be useful in patients with a remission of RHG for prevention of its relapses.


Subject(s)
Antiviral Agents/therapeutic use , Herpes Genitalis/drug therapy , Herpes Genitalis/immunology , Interferon Inducers/therapeutic use , Interferon-alpha/drug effects , Interferon-gamma/drug effects , Killer Cells, Natural/drug effects , RNA, Double-Stranded/therapeutic use , RNA, Fungal/therapeutic use , Adult , Cytotoxicity Tests, Immunologic , Drug Evaluation , Female , Herpes Genitalis/blood , Humans , Interferon-alpha/blood , Interferon-gamma/blood , Killer Cells, Natural/immunology , Male , Recurrence , Remission Induction
2.
Klin Med (Mosk) ; 70(1): 67-70, 1992 Jan.
Article in Russian | MEDLINE | ID: mdl-1318984

ABSTRACT

Interferon inductor larifan used parenterally was combined with herpetic vaccine to treat severe recurrent herpes in 32 patients. This combination therapy started at initiation of herpetic infection activation and resulted in amelioration of the clinical symptoms of the recurrence, a more favourable course of the disease due to stimulation of the interferon system and natural killer activity. In combination the above modalities proved more effective than in monotherapy.


Subject(s)
Antiviral Agents/therapeutic use , Herpes Simplex/therapy , Interferon Inducers/therapeutic use , Simplexvirus/immunology , Viral Vaccines/therapeutic use , Adult , Combined Modality Therapy , Drug Evaluation , Female , Humans , Male , Middle Aged , Organic Chemicals , Recurrence , Remission Induction , Time Factors
6.
Klin Med (Mosk) ; 68(3): 71-4, 1990 Mar.
Article in Russian | MEDLINE | ID: mdl-2370760

ABSTRACT

The paper presents analysis of current knowledge on etiology and immunopathogenesis of multiform exudative erythema (MEE). Among a variety of pathogenetic actions of herpes simplex on immune system are those relevant to MEE onset. These variants are dealt with in detail. The view on MEE as resultant from herpes simplex infection promises appearance of new prospective modes of etiotropic therapy.


Subject(s)
Erythema Multiforme/etiology , Herpes Simplex/complications , Adult , Antigen-Antibody Complex/analysis , Complement System Proteins/analysis , Erythema Multiforme/diagnosis , Erythema Multiforme/immunology , Female , Herpes Simplex/diagnosis , Herpes Simplex/immunology , Humans , Immunoglobulin M/analysis , Male , Recurrence
7.
Feldsher Akush ; 54(7): 61, 1989 Jul.
Article in Russian | MEDLINE | ID: mdl-2529142
9.
Vestn Dermatol Venerol ; (12): 56-60, 1989.
Article in Russian | MEDLINE | ID: mdl-2534455

ABSTRACT

Roakkutan was used in the treatment of 49 patients with severe acne vulgaris and 8 patients with rosacea. The treatment was highly effective. The primary and maintenance daily doses of the drug are suggested and the terms of therapy defined.


Subject(s)
Acne Vulgaris/drug therapy , Isotretinoin/therapeutic use , Rosacea/drug therapy , Adolescent , Adult , Chronic Disease , Drug Evaluation , Female , Humans , Isotretinoin/administration & dosage , Isotretinoin/adverse effects , Male , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...